OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Breaking Through the Barrier	26
Molecular Pathology of Ovarian Epithelial Neoplasms	22
Molecular Detection of Oncogenic Gene Rearrangements	22
Contributors	19
Current Topics in Molecular Diagnostics and Precision Medicine	19
Contents	19
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	18
Digital Imaging and AI Pre-classification in Hematology	17
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	16
Is It Possible to Test for Viral Infectiousness?	13
Molecular Oncology Diagnostics	12
Contributors	12
Copy Number Analysis in Cancer Diagnostic Testing	12
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	11
Infant Acute Leukemia	10
Gene Rearrangement Detection in Pediatric Leukemia	10
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	10
Point-of-Care Drug Testing	9
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	9
Hematopathologic Correlates of CAR T-Cell Therapy	8
Opportunities and Challenges with Artificial Intelligence in Genomics	8
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia	8
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management	7
Contributors	7
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	7

Contributors	7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	6
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	6
Cell-free Nucleic Acids in Cancer	6
Contents	6
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	6
Update on Acute Leukemias of Ambiguous Lineage	6
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	6
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry	6
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	5
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting	5
Copyright	5
Molecular Biomarkers of Response to Cancer Immunotherapy	5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	5
Artificial Intelligence for Clinical Flow Cytometry	5
Contents	5
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry	5
The Evolving Role of Molecular Diagnostics in Pathology	5
Flow Cytometry and Platelets	5
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
Molecular Alterations in Pediatric Solid Tumors	5
Copyright	4
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2	4
Utility of Single-Gene Testing in Cancer Specimens	4
Rapid Antigen Assays for SARS-CoV-2	4
Artificial Intelligence in the Clinical Laboratory	4
Copyright	4
Contents	4
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	4
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	4
Electronic Health Record Optimization for Artificial Intelligence	4
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	4
Contributors	4
Diagnostic Stewardship for Multiplex Respiratory Testing	4
Taking Center Stage	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Steps Forward to a Fair and Inclusive Blood Supply	4
Point of Care Molecular Testing	4
Update on Ovarian Sex Cord–Stromal Tumors	3
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation	3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
Copyright	3
Transfusion Reactions and Adverse Events	3
Molecular Methods	3
Updates in Blood Banking and Transfusion Medicine	3
Transfusion Medicine Informatics	3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3
Reactive Lymphadenopathies	3

Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	2
Donor Screening and Deferral	2
Platelet Transfusion	2
Clinical Cytometry for Platelets and Platelet Disorders	2
A Winding Road to Health Care Equity in Sickle Cell Disease	2
Molecular Pathology of Breast Tumors	2
Contents	2
History, Advances, and Challenges of Sickle Cell Disease Treatment	2
Current Topics in Molecular Diagnostics and Precision Medicine	2
Childhood Myelodysplastic Syndrome	2
Analytical Principles of Cancer Next Generation Sequencing	2
Update on Pediatric and Young Adult Mature Lymphomas	2
Specimen Validity Testing in the Toxicology Laboratory	2
Flow Cytometric Assessment of Malignant Hematologic Disorders	2
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia	2